YH004
YH004 is an anti-CD137 agonistic monoclonal antibody, with immunostimulating and antineoplastic activities. YH004 activates CD137 expressed on a variety of leukocyte subsets including activated T lymphocytes and natural killer cells. YH004 enhances CD137-mediated signaling and induces cytotoxic T-lymphocyte (CTL) proliferation, cytokine production and promotes anti-tumor response mediated by CTL. YH004 induces NK-mediated tumor cell killing and suppresses the immunosuppressive activity of regulatory T cells. YH004 can be studied in anticancer research[1].
Product Specifications
UNSPSC
12352203
Target
Biochemical Assay Reagents
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
References & Citations
[1]Chaoshe Guo, et al., Abstract 522: Optimization of novel anti-4-1BB antibodies on Biocytogen's in vivo drug screening platform.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Tbc1d17 (NM_001042655) Mouse Tagged Lenti ORF Clone
Connexin 30.3 (CX30.3, Gap Junction Beta 5 Protein, CXB5) (AP)
Connexin 30.3 (CX30.3, Gap Junction Beta 5 Protein, CXB5) (AP)
